Cerity Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Buy
53,926
+15,759
+41% +$37K ﹤0.01% 3019
2025
Q4
$103K Buy
38,167
+20,493
+116% +$67.3K ﹤0.01% 2741
2025
Q3
$74.8K Buy
+17,674
New +$77.7K ﹤0.01% 2657
2022
Q1
Sell
-8,709
Closed -$285K 1003
2021
Q4
$285K Buy
8,709
+9
+0.1% +$362 ﹤0.01% 793
2021
Q3
$357K Buy
+8,700
New +$316K 0.01% 531

Other funds holding GDRX

Cerity Partners's GDRX Position: Q1 2026 in Review

Cerity Partners increased its GoodRx Holdings (GDRX) stake by 41% in Q1 2026, buying an estimated $37K and bringing the position to 53,926 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

Cerity Partners first reported a position in GDRX in Q3 2021 and has held it in 5 quarters since. The position peaked at $357K in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Cerity Partners held 53,926 shares of GoodRx Holdings worth $106K as of Q1 2026.
  • Cerity Partners bought 15,759 GoodRx Holdings shares in Q1 2026, an estimated $37K.
  • GoodRx Holdings made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3019 holding.
  • Cerity Partners first reported a position in GoodRx Holdings in Q3 2021 and has held it in 5 quarters since.
  • Cerity Partners's GoodRx Holdings position peaked at $357K in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.